NSE · BIOPOL
Biopol Chemicals Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹81 Cr with net profit ₹9 Cr — a 11.03% net margin, versus 8.76% the period before.
Shareholding
As of 2026-06-30
- Promoter65.81%
- Public28.95%
- FII4.7%
- DII0.54%
368 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 3.39× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ST-ASM · ASM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Chemicals · ranked #123 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹2,02,426 Cr | 101.65 | 32.28 | 26.72% | 17.54% |
| Pidilite Industries Ltd. | ₹1,59,705 Cr | 60.3 | 14.74 | 22.61% | 17.2% |
| SRF Ltd. | ₹74,669 Cr | 33.32 | 5.29 | 13.07% | 13.01% |
| Linde India Limited | ₹53,111 Cr | 97.2 | 12.45 | 12.87% | 20.59% |
| Gujarat Fluorochemicals Ltd. | ₹52,578 Cr | 85.12 | 6.76 | 7.13% | 11.41% |
| Navin Fluorine International Ltd. | ₹44,646 Cr | 56.14 | 11.23 | 16.69% | 21.73% |
| Godrej Industries Ltd. | ₹37,805 Cr | 30.9 | 3.39 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹33,491 Cr | 41.9 | 7.12 | 15.96% | 16.07% |
| Deepak Nitrite Ltd. | ₹22,448 Cr | 28.34 | 3.85 | 9.43% | 9.13% |
| Aether Industries Limited | ₹21,771 Cr | 90.72 | 8.88 | 8.94% | 19.11% |
| Biopol Chemicals Limited(this company) | ₹51 Cr | 25.11 | 1.02 | 17.98% | 12.2% |
AI analysis
AI-generated · google/gemini-2.5-flashBiopol Chemicals Limited is listed with a market capitalization of Rs 109 Cr. The company reported revenue of Rs 49.15 Cr in the latest annual period.
Positives
- +Revenue grew from Rs 25.47 Cr in Mar 2024 to Rs 49.15 Cr in Mar 2025.
- +Promoter holding is 65.81% as of March 31, 2026.
- +Return on Capital Employed (ROCE) was 23.26% in the latest period.
- +The debt-to-equity ratio is 0.49, indicating a manageable level of debt.
Negatives
- −The company's earnings per share (EPS) is Rs 0.00 according to the provided overview metrics, despite reporting an EPS of Rs 5.49 for Mar 2025.
- −The profit margin is 0.00% according to the provided overview metrics, despite reporting a net profit of Rs 4.34 Cr for Mar 2025.
- −No dividend yield is reported (0.00%).
- −There are no quarterly results disclosed in the provided data.
Financial Performance
Biopol Chemicals Limited's revenue increased from Rs 25.47 Cr in Mar 2024 to Rs 49.15 Cr in Mar 2025. Net profit also rose from Rs 2.96 Cr in Mar 2024 to Rs 4.34 Cr in Mar 2025. Earnings per share (EPS) grew from Rs 3.75 in Mar 2024 to Rs 5.49 in Mar 2025.
Profitability & Returns
The company reported a Return on Equity (ROE) of 17.98% and a Return on Capital Employed (ROCE) of 23.26%. The P/E ratio stands at 27.01. The book value per share is Rs 33.43.
Balance Sheet
Biopol Chemicals Limited has a debt-to-equity ratio of 0.49, indicating moderate leverage. The company's market capitalization is Rs 109 Cr.
Ownership & Pledges
As of March 31, 2026, promoters held 65.81% of the shares. Public shareholding was 21.98%, FIIs held 9.30%, and DIIs held 2.92%. Institutions collectively held 12.22% of the shares. There were no promoter share pledges reported.
Data as of — price: 2026-09-11 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.